Lipid-based nanocarrier-enabled combination therapy for breast cancer: overcoming drug resistance toward precision oncology

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY · Published 2026-07-28 · DOI 10.1007/s00210-026-05735-6

Authors (3)

Abdul Shadab, Md. Faheem Haider, Mohammad Abohassan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shadab, A., Haider, M., Abohassan, M. (2026). Lipid-based nanocarrier-enabled combination therapy for breast cancer: overcoming drug resistance toward precision oncology. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. https://doi.org/10.1007/s00210-026-05735-6

Related articles